acetylcysteine has been researched along with angiotensin i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldershvile, J; Boesgaard, S; Christensen, S; Dige-Petersen, H; Giese, J; Poulsen, HE | 1 |
| Chen, J; Cheng, F; Feng, J; Lan, J; Lei, Y; Mei, W; Xu, Q; Zeng, B; Zhai, Y; Zhang, W; Zhen, Y; Zheng, D | 1 |
1 trial(s) available for acetylcysteine and angiotensin i
| Article | Year |
|---|---|
N-acetylcysteine inhibits angiotensin converting enzyme in vivo.
Topics: Acetylcysteine; Adolescent; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Interactions; Female; Heart Rate; Humans; Isosorbide Dinitrate; Kidney; Male; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin | 1993 |
1 other study(ies) available for acetylcysteine and angiotensin i
| Article | Year |
|---|---|
Angiotensin-(1-7) protects cardiomyocytes against high glucose-induced injuries through inhibiting reactive oxygen species-activated leptin-p38 mitogen-activated protein kinase/extracellular signal-regulated protein kinase 1/2 pathways, but not the leptin
Topics: Acetylcysteine; Angiotensin I; Animals; Anthracenes; Apoptosis; Cell Line; Glucose; Imidazoles; Leptin; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Myocytes, Cardiac; Peptide Fragments; Pyridines; Rats; Reactive Oxygen Species | 2017 |